Public-registry site landscape for NCT03781063, a Locally Advanced or Metastatic Breast Cancer study sponsored by Sermonix Pharmaceuticals Inc.. All data below is from public sources; Eichor is not affiliated with the sponsor.
| Trial | NCT03781063 (registry record) |
| Sponsor | Sermonix Pharmaceuticals Inc. |
| Condition(s) | Locally Advanced or Metastatic Breast Cancer |
| Phase | PHASE2 |
| Listed sites | 51 |
| Site countries | United States, Canada, Israel |
Eichor generates a preliminary site-risk snapshot for NCT03781063 — how the roster screens on competing-trial load, enrollment track record, and PI–indication fit — free, usually same day. Request it here →